桥本甲状腺炎伴IgG4阳性浆细胞增多:采用甲状腺特异性诊断标准或可识别早期IgG4甲状腺炎
该研究回顾性分析120例桥本甲状腺炎(HT)病例,比较综合诊断标准(CVC:IgG4+浆细胞>10/HPF且IgG4+/IgG+浆细胞比例>40%)与甲状腺特异性诊断标准(CVT:IgG4+浆细胞>20/HPF且IgG4+/IgG+浆细胞比例>30%)对IgG4甲状腺炎的诊断效能。两种标准均能区分IgG4甲状腺炎与非IgG4甲状腺炎,但CVT能更好地识别伴更多纤维化改变的临界病例,可能代表IgG4甲状腺炎的早期病变。作者提出新的临床和病理诊断线索以帮助内分泌科和病理科医生提高对IgG4甲状腺炎的早期识别。
要点
- CVC(IgG4+浆细胞>10/HPF且IgG4+/IgG+比例>40%)与CVT(IgG4+浆细胞>20/HPF且IgG4+/IgG+比例>30%)均能区分IgG4甲状腺炎与非IgG4甲状腺炎。
- 120例HT可分为四组:A组25例同时满足CVC和CVT,D组85例均不满足,B组和C组仅满足其一。
- 仅满足CVT的B组病例在组织学上表现出类似IgG4甲状腺炎的特征,提示CVT更利于识别临界病例。
核心结论
- 尽管两种截断值均能有效区分IgG4甲状腺炎与非IgG4甲状腺炎,但甲状腺特异性截断值(CVT:IgG4+浆细胞>20/HPF且IgG4+/IgG+浆细胞比例>30%)能更好地识别伴更多纤维化改变的HT临界病例,这些病例可能代表IgG4甲状腺炎的早期病变。
- 作者提出了一系列新的临床和病理诊断线索,供内分泌科和病理科医生参考,以提高对IgG4甲状腺炎的早期识别。
研究设计与样本
- 回顾性分析了120例桥本甲状腺炎(HT)病例。
- 根据综合诊断标准(CVC:IgG4+浆细胞>10/HPF且IgG4+/IgG+浆细胞比例>40%)和甲状腺特异性诊断标准(CVT:IgG4+浆细胞>20/HPF且IgG4+/IgG+浆细胞比例>30%)将病例分为IgG4甲状腺炎或非IgG4甲状腺炎。
- 比较了两种亚型的临床、血清学、超声和组织病理学特征,以及使用不同阈值诊断为IgG4甲状腺炎的病例。
主要发现
- CVC和CVT均能识别出被诊断为IgG4甲状腺炎病例的相同的一组独特的临床、实验室和超声特征。
- 120例HT均可分为四组:A组25例同时满足CVC和CVT,被归为IgG4甲状腺炎;D组85例不满足任一截断值;B组和C组为仅满足一个阈值的临界病例。
- 基于组织学评估,仅满足CVT的B组病例表现出与IgG4甲状腺炎相似的组织学特征。
关键数值与推荐
- 综合诊断标准(CVC):IgG4+浆细胞>10/HPF且IgG4+/IgG+浆细胞比例>40%。
- 甲状腺特异性诊断标准(CVT):IgG4+浆细胞>20/HPF且IgG4+/IgG+浆细胞比例>30%。
临床怎么用
- 作者提出了一系列新的临床和病理诊断线索,供内分泌科和病理科医生参考,以提高对IgG4甲状腺炎的早期识别。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: A subset of Hashimoto's thyroiditis (HT), reported as immunoglobulin G4 (IgG4) thyroiditis, is characterized by IgG4+ plasma cell-rich inflammation and marked sclerotic changes, which suggests a close relationship with immunoglobulin G4-related disease (IgG4-RD). However, to date, there is no consensus regarding the cutoff values used to define a significant IgG4+ plasma cell count in thyroid inflammation. We, therefore, sought to validate both the cutoff value of the comprehensive diagnostic criteria (CVC) and the cutoff value of thyroid-specific diagnostic criteria (CVT) for diagnosing IgG4 thyroiditis. Methods: One hundred twenty cases of HT were retrospectively reviewed. According to the CVC (IgG4+ plasma cells >10/HPF (high-power field) and IgG4+/IgG+ plasma cell ratio >40%) and the CVT (IgG4+ plasma cells >20/HPF and IgG4+/IgG+ plasma cell ratio >30%), cases were subclassified as IgG4 thyroiditis or non-IgG4 thyroiditis. Clinical, serological, sonographic, and histopathological characteristics of the two subsets, and the cases diagnosed as IgG4 thyroiditis using different thresholds were compared. Results: Both the CVC and CVT identified the same set of distinct clinical, laboratory, and sonographic features of the cases diagnosed as IgG4 thyroiditis. All 120 cases of HT were able to be divided into four distinct groups. Group A included the 25 cases who were assigned as IgG4 thyroiditis by both the CVC and CVT, whereas Group D included the 85 cases who did not meet either of the cutoff values. Group B and Group C comprised the borderline cases who only met one of the two thresholds. Based on histological evaluation, the cases in Group B who met the CVT demonstrated similar histological features of IgG4 thyroiditis. Conclusions: Although both of the cutoff values can efficiently distinguish IgG4 thyroiditis from its non-IgG4 counterpart, the thyroid-specific cutoff value (CVT, IgG4+ plasma cells >20/HPF, and IgG4+/IgG+ plasma cell ratio >30%) can better identify borderline cases of HT with more fibrotic changes, which may represent an early phase lesion of IgG4 thyroiditis. We propose a new series of clinical and pathological diagnostic clues for both endocrinologists and pathologists to improve the early recognition of IgG4 thyroiditis.
引用
- Li Y, Wang X, Liu Z, et al. Hashimoto's Thyroiditis with Increased IgG4-Positive Plasma Cells: Using Thyroid-Specific Diagnostic Criteria May Identify Early Phase IgG4 Thyroiditis. Thyroid. 2020. PMID: 31861966. doi:10.1089/thy.2019.0063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。